Markus M. Chmielewski

Robert Koch Str. 21
Koeln, NW 50931, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy.

Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy.

Journal: Experimental hematology & oncology

Published: January 05, 2026

Bridge over troubled cells: bone marrow stromal cells transfer mitochondria to boost T cells.

Bridge over troubled cells: bone marrow stromal cells transfer mitochondria to boost T cells.

Journal: Signal transduction and targeted therapy

Published: November 13, 2024

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

Journal: Cancer cell

Published: August 25, 2024

An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL.

An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL.

Journal: Cell reports. Medicine

Published: September 22, 2022

Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges.

Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges.

Journal: Frontiers in immunology

Published: May 02, 2022

Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing.

Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing.

Journal: Frontiers in immunology

Published: January 29, 2022

Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies.

Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies.

Journal: Blood cancer discovery

Published: January 20, 2022

IL12 integrated into the CAR exodomain converts CD8+ T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors.

IL12 integrated into the CAR exodomain converts CD8+ T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 19, 2020

CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin's lymphoma and tumor-supportive follicular T helper cells.

CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin's lymphoma and tumor-supportive follicular T helper cells.

Journal: Nature communications

Published: November 14, 2019

Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.

Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.

Journal: Blood

Published: September 26, 2019

Benchmarking an 11-qubit quantum computer.

Benchmarking an 11-qubit quantum computer.

Journal: Nature communications

Published: June 05, 2019

FimH-based display of functional eukaryotic proteins on bacteria surfaces.

FimH-based display of functional eukaryotic proteins on bacteria surfaces.

Journal: Scientific reports

Published: March 04, 2019

Showing 1-12 of 33

Last Updated: 09/26/2026